Quick Takeaways
- Nantahala Capital Management, LLC filed SCHEDULE 13G/A for Immunic, Inc. Common Stock, $0.0001 par value (IMUX).
- Disclosed ownership: 8.2%.
- Date of event: 31 Dec 2025.
Nantahala Capital Management, LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Immunic, Inc. Common Stock, $0.0001 par value (IMUX)
- Filing Manager
- Nantahala Capital Management, LLC
- Reporting Manager
- Nantahala Capital Management, LLC
- Symbol
- IMUX
- Shares outstanding
- 126,257,981 shares
- Disclosed Ownership
- 10,378,406 shares
- Ownership
- 8.2%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 Feb 2026, 17:05:18 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 14 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Nantahala Capital Management, LLC disclosed 8.2% ownership in Immunic, Inc. Common Stock, $0.0001 par value (IMUX) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 14 Aug 2025.
- Current filing was accepted on 13 Feb 2026, 17:05.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 8.2% | 10,378,406 | 0 | 10,378,406 | /s/ Taki Vasilakis | Taki Vasilakis / Chief Compliance Officer | |
| Wilmot B. Harkey | 8.2% | 10,378,406 | 0 | 10,378,406 | /s/ Wilmot B. Harkey | Wilmot B. Harkey | |
| Daniel Mack | 8.2% | 10,378,406 | 0 | 10,378,406 | /s/ Daniel Mack | Daniel Mack |